TriangleFOR PATIENTS · SOURCE READING
Treatment Option Overview for Transitional Cell Cancer of the Renal Pelvis and Ureter
Source: Transitional Cell Cancer of the Renal Pelvis and Ureter Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: May 16, 2025 · Captured 2026-09-09.
Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary. Independent clinical review is pending.
Continue within this section
Key Points →There are different types of treatment for patients with transitional cell cancer of the renal pelvis and ureter. →The following type of treatment is used: →New types of treatment are being tested in clinical trials. →Treatment for transitional cell cancer of the renal pelvis and ureter may cause side effects. →Follow-up care may be needed. →
Preserved source evidence · Independent clinical review pending · Not medical advice